What are CD22-targeting antibody-drug conjugate drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Question

Accepted Answer

CD22-targeting antibody-drug conjugate drugs are pharmacologic agents that share a common mechanism (typically targeting CD22). 0 are currently marketed, with 1 more in clinical development.

CD22-targeting antibody-drug conjugate

Targets

Phase 2 pipeline (1)